North America Intra Ocular Lens Market Industry: Market Size & Forecast 2026

Intraocular lenses are artificial lenses implanted in the eye during cataract surgery or as a refractive correction procedure. In 2025, North America commands roughly 35-38% of the global IOL market, valued at approximately $1.84 billion out of a global market of around $5.1 billion. The region is expected to grow at a steady pace through the decade as demographic and clinical trends support sustained demand.

• •North America held approximately 37-38% of the global IOL market in 2025, with a value around $1.74 billion to $1.84 billion.
• •The global IOL market is valued at approximately $5.1 billion in 2025, with projections reaching between $8.8 billion and $11.2 billion by 2030-2035.
• •The United States leads the region, accounting for over 35% of global IOL revenue, fueled by one of the highest cataract surgery volumes in the world.

The primary engine of growth is the rising prevalence of cataracts, particularly among the aging baby boomer generation and diabetic populations, both of which are expanding in North America. Advances in surgical techniques and the growing consumer preference for reduced dependence on glasses are accelerating adoption of premium IOLs, such as multifocal, extended depth-of-focus, and toric lenses.

• •An aging population and rising cataract incidence, especially among diabetic patients, are increasing the volume of cataract surgeries across the region.
• •Growing demand for premium IOLs, including multifocal, EDOF, and toric lenses, is shifting product mix toward higher-margin segments.
• •Favorable reimbursement policies in the United States and Canada support broader patient access to advanced IOL technologies.

The North American IOL market is segmented by product type into monofocal, multifocal, EDOF, and toric lenses, with premium categories experiencing the fastest growth. The United States accounts for the vast majority of regional revenue, while Canada represents a smaller but steady market driven by universal healthcare coverage. Within the product mix, monofocal lenses remain the largest segment by volume, but premium lenses are gaining share.

• •Monofocal IOLs dominate by procedure volume, while multifocal and EDOF premium lenses are the fastest-growing category.
• •The United States represents the dominant country-level market in North America, with over 35% of global IOL revenue.
• •Material types span acrylic, silicone, and PMMA, with foldable acrylic lenses being the most widely implanted.

What are the recent trends and outlook?

Emerging trends include the increasing adoption of femtosecond laser-assisted cataract surgery, which improves precision and outcomes, and the integration of AI-driven diagnostic tools that support lens selection and surgical planning. The market is also seeing growing interest in accommodating and extended depth-of-focus lenses that offer intermediate vision without the visual disturbances sometimes associated with traditional multifocal designs. Looking ahead, the North American IOL market is expected to maintain steady growth through the decade.

• •Femtosecond laser-assisted cataract surgery is gaining adoption, supporting higher uptake of premium IOLs.
• •AI-powered pre-surgical planning and patient-specific lens selection tools are beginning to shape surgeon decision-making.
• •Continuous product innovation, particularly in EDOF and next-generation multifocal designs, is expected to drive premium segment growth.